PL3162363T3 - Preparat złożony zawierający warstwę powłoki filmu zawierającą składnik aktywny - Google Patents

Preparat złożony zawierający warstwę powłoki filmu zawierającą składnik aktywny

Info

Publication number
PL3162363T3
PL3162363T3 PL15816054T PL15816054T PL3162363T3 PL 3162363 T3 PL3162363 T3 PL 3162363T3 PL 15816054 T PL15816054 T PL 15816054T PL 15816054 T PL15816054 T PL 15816054T PL 3162363 T3 PL3162363 T3 PL 3162363T3
Authority
PL
Poland
Prior art keywords
active ingredient
coating layer
film coating
containing film
composite preparation
Prior art date
Application number
PL15816054T
Other languages
English (en)
Inventor
Hyung Seo Kim
Jung Hyun Cho
Young Keun Choi
Kyeong Soo Kim
Jin Cheul Kim
Yong Il Kim
Jae Hyun Park
Jong Soo Woo
Original Assignee
Hanmi Pharm. Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm. Co., Ltd. filed Critical Hanmi Pharm. Co., Ltd.
Priority claimed from PCT/KR2015/006743 external-priority patent/WO2016003181A1/ko
Publication of PL3162363T3 publication Critical patent/PL3162363T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15816054T 2014-06-30 2015-06-30 Preparat złożony zawierający warstwę powłoki filmu zawierającą składnik aktywny PL3162363T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20140081223 2014-06-30
PCT/KR2015/006743 WO2016003181A1 (ko) 2014-06-30 2015-06-30 활성성분-함유 필름 코팅층을 포함하는 복합제제
EP15816054.9A EP3162363B1 (en) 2014-06-30 2015-06-30 Composite preparation comprising active ingredient-containing film coating layer

Publications (1)

Publication Number Publication Date
PL3162363T3 true PL3162363T3 (pl) 2020-06-15

Family

ID=55169028

Family Applications (2)

Application Number Title Priority Date Filing Date
PL15815459T PL3150201T3 (pl) 2014-06-30 2015-06-30 Preparat kompozytowy zawierający błonową warstwę powlekającą zawierającą inhibitor 5-reduktazy i sposób wytwarzania preparatu kompozytowego
PL15816054T PL3162363T3 (pl) 2014-06-30 2015-06-30 Preparat złożony zawierający warstwę powłoki filmu zawierającą składnik aktywny

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL15815459T PL3150201T3 (pl) 2014-06-30 2015-06-30 Preparat kompozytowy zawierający błonową warstwę powlekającą zawierającą inhibitor 5-reduktazy i sposób wytwarzania preparatu kompozytowego

Country Status (8)

Country Link
EP (2) EP3162363B1 (pl)
KR (3) KR20160002411A (pl)
CN (2) CN106659690B (pl)
ES (2) ES2772137T3 (pl)
PH (2) PH12016502537A1 (pl)
PL (2) PL3150201T3 (pl)
PT (2) PT3150201T (pl)
RU (1) RU2696563C9 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170113459A (ko) * 2016-03-31 2017-10-12 한미약품 주식회사 타다라필 및 암로디핀 함유 고형 복합제제
MX2018011642A (es) * 2016-03-31 2019-03-14 Hanmi Pharm Ind Co Ltd Preparacion en capsula compuesta que contiene tadalafilo y tamsulosina con estabilidad y tasa de elucion mejoradas.
WO2019035679A2 (ko) 2017-08-18 2019-02-21 (주)인벤티지랩 피나스테라이드를 포함하는 마이크로 입자 및 이의 제조 방법
KR20200099901A (ko) 2019-02-15 2020-08-25 (주)인벤티지랩 피나스테라이드를 포함하는 마이크로 입자를 함유한 피하 주사용 조성물
KR102157124B1 (ko) 2019-12-23 2020-09-18 (주)인벤티지랩 피나스테라이드를 포함하는 서방성 주사용 조성물
US20240075028A1 (en) 2020-12-31 2024-03-07 Dong Kook Pharm. Co., Ltd. Pharmaceutical composition comprising tadalafil or pharmaceuticallly acceptable salt thereof and dutasteride or pharmaceuticallly acceptable salt thereof exhibiting novel dissolution rate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005016981A1 (de) * 2005-04-13 2006-10-19 Bayer Healthcare Ag Kombination zur Therapie bei benigner Prostatahyperplasie
EP2210595A1 (en) * 2009-01-14 2010-07-28 LEK Pharmaceuticals d.d. Active coating of pharmaceutical dosage forms
EP2515882A2 (en) * 2009-12-22 2012-10-31 Abbot Healthcare Private Limited Controlled release pharmaceutical composition
KR101193495B1 (ko) * 2010-02-01 2012-10-23 한미사이언스 주식회사 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물
WO2012127495A2 (en) * 2011-02-28 2012-09-27 Titan Laboratories Pvt. Ltd. A pharmaceutical composition and process for preparation thereof
KR101310710B1 (ko) * 2011-03-23 2013-09-27 한미약품 주식회사 오메가-3 지방산 에스테르 및 HMG-CoA 환원효소 억제제를 포함하는 경구용 복합 조성물
KR20140013436A (ko) * 2012-07-24 2014-02-05 한미약품 주식회사 메트포르민 및 로수바스타틴을 포함하는 경구용 복합 제제
KR102240429B1 (ko) * 2013-05-06 2021-04-15 한미약품 주식회사 로수바스타틴 또는 이의 약학적으로 허용되는 염이 함유된 필름 코팅층을 포함하는 복합 제형
WO2014182003A1 (en) * 2013-05-06 2014-11-13 Hanmi Pharm. Co., Ltd. Composite formulation comprising a film coating layer containing rosuvastatin or a pharmaceutically acceptable salt thereof

Also Published As

Publication number Publication date
CN106659692A (zh) 2017-05-10
CN106659690A (zh) 2017-05-10
PT3162363T (pt) 2020-02-21
EP3150201B1 (en) 2020-02-19
PL3150201T3 (pl) 2020-09-21
KR101780740B1 (ko) 2017-09-26
PH12016502537A1 (en) 2017-04-10
EP3162363A4 (en) 2018-01-03
KR20170026424A (ko) 2017-03-08
EP3150201A1 (en) 2017-04-05
KR101780739B1 (ko) 2017-09-26
RU2016148824A3 (pl) 2018-10-10
RU2016148824A (ru) 2018-07-30
EP3162363A1 (en) 2017-05-03
ES2772137T3 (es) 2020-07-07
KR20160002411A (ko) 2016-01-07
EP3162363B1 (en) 2020-01-08
RU2696563C2 (ru) 2019-08-05
RU2696563C9 (ru) 2019-10-02
EP3150201A4 (en) 2018-01-03
PT3150201T (pt) 2020-03-31
ES2781110T3 (es) 2020-08-28
CN106659690B (zh) 2020-08-18
KR20160002412A (ko) 2016-01-07
PH12016502536A1 (en) 2017-04-10
CN106659692B (zh) 2020-08-18

Similar Documents

Publication Publication Date Title
HK1219064A1 (zh) 藥物塗層
EP3229851A4 (en) Medical device coating with a biocompatible layer
HK1218260A1 (zh) 包含含有瑞舒伐他汀或其可藥用鹽的膜包衣層的複合製劑
PL2990195T3 (pl) Wielowarstwowa folia kompozytowa z wytłoczonym wzorem i laminowana w postaci stopu
EP3315571A4 (en) Coating film
EP3029092A4 (en) Coating film
EP3347306A4 (en) GRAPHENE-BASED CIRCULAR MATERIALS WITH LOW NUMBER OF LAYERS
EP3238236A4 (en) Via blocking layer
EP3388237A4 (en) MULTILAYER FILM WITH HARD COATING
PT3162363T (pt) Preparação compósita que compreende uma camada de revestimento de película contendo um ingrediente ativo
EP3202395A4 (en) Soft capsule coating film
EP3354690A4 (en) OXYGEN PERMEABLE FOIL
DK3623426T3 (en) Polymer-metal compound composite ink and preparation method and use thereof
EP3122337A4 (en) Abuse deterrent immediate release coated reservoir solid dosage form
EP3057792A4 (en) Breathable composite film
EP3475973A4 (en) BLOCKING LAYER FOR CONTACT
EP3023452A4 (en) Coated film
PL2727724T3 (pl) Folia jednowarstwowa lub wielowarstwowa
EP3165630A4 (en) Hard coating film
EP3130461A4 (en) Composite film and method for manufacturing same
EP3050702A4 (en) Coated film
ZA201707811B (en) Silicone gel-coated adhesive layer structure
EP3109893A4 (en) Composite substrate
EP3015496A4 (en) Coating film
PL3476591T3 (pl) Folia kompozytowa